Skip to content

Post-emergency Management of Patients With Transient Ischemic Attack

Post-emergency Management of Patients With Transient Ischemic Attack

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06170034
Enrollment
49
Registered
2023-12-14
Start date
2023-11-16
Completion date
2024-06-16
Last updated
2025-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transient Ischemic Attack

Keywords

Emergency, Cerebral RMI, Guidelines compliance

Brief summary

A transient ischemic attack (TIA) is a momentary neurological dysfunction due to a brief cessation of blood flow to a region of the brain, resulting in typical signs of stroke (hemiplegia, aphasia, dysarthria), but whose clinical symptoms typically last less than an hour, with no visible lesion on imaging. This diagnosis remains difficult and is essentially based on the clinical judgment of the physician. Because a TIA can be a pre-alarm for stroke in 20-30% of cases, it needs to be treated appropriately and as early as possible in the emergency department. Stroke rates after untreated TIA are 5% within 48 hours, 10% within one month and 20% within one year. This risk is calculated using the ABCD² score which is based on the patient's risk factors and the clinical manifestations of TIA. Patients with a score ≥ 3 should be hospitalized as soon as possible for a complete medical evaluation. However, this score has not been scientifically validated, and several specialists agree that all TIAs should be evaluated immediately. Preventing stroke is a major public health issue because it is a serious, disabling and sometimes fatal disease. Given the seriousness of the progression from TIA to stroke, the French National Authority for Health has issued a series of management recommendations. However, in practice, these guidelines remain complicated to follow and patients management may vary and be more or less effective. Therefore, the aim of this study is to highlight the differences in how inpatients and outpatients are managed. Following these observations, solutions will be sought to make the care and management of these patients more efficient and more in line with recommendations.

Interventions

Satisfaction questionnaire to assess how TIA patients feels about their medical care.

OTHERMedical care questionnaire

Recording appointments and results of examinations and consultations in TIA management

Sponsors

Centre Hospitalier Henri Duffaut - Avignon
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient over 18 years old. * Consultation in the emergency department. * Suspected TIA diagnosed by emergency physician. * Duration of TIA symptoms \<1 hour.

Exclusion criteria

* Validation MRI performed prior to suspected TIA. * Patient hospitalized for a condition other than TIA, including stroke. * Patient referred to another hospital for further examination. * Pregnant women. * Patient unable to understand and answer a questionnaire. * Patient under legal protection.

Design outcomes

Primary

MeasureTime frame
Assess time between arrival in the emergency department for suspected TIA patients and MRI.Baseline

Secondary

MeasureTime frame
Time between arrival in the emergency department and MRI by departments.Baseline
Time between arrival in the emergency department and MRI by ABCD² score.Baseline
Percentage of patients with complete TIA management by departments.Baseline
Hospitalization times according to care unitsBaseline
Hospitalization times according to complete TIA managementBaseline
Percentage of patients with secondary event, according to complete TIA managementBaseline
Number of outpatients without complete TIA management one month after TIA.At 1 month follow-up
Patient satisfaction with a short questionnaireAt 1 month follow-up

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026